Introduction
The incidence of fungal infections has increased over the last two decades, and Candida spp. have been reported as predominant mycotic pathogens (1) . In recent years, because of excessive use of antibacterial antibiotics, immunosuppressors, and cytotoxins, opportunistic mycoses become prominent. To combat the increasing number of fungal pathogens and the growing burden of resistance, new antifungal compounds are required (2); therefore, new, more active or better-tolerated compounds are being developed (3) (4) (5) .
Recently, there has been growing concern of rapidly increasing resistance of bacteria to the antibacterial preparations in markets. Although at present many and various drugs are used for the treatment of infections, more effective and safe preparations are still missing (6) (7) (8) .
For a number of years, the Department of Drug Chemistry, the Lithuanian University of Health Sciences, has investigated new thiazolidinone derivatives, which are obtained by substituting the second position with an amine moiety, such as sulfanilamides or other amines, which have antimicrobial pharmacophores (9) (10) (11) . The selection of such antimicrobial pharmacophores was determined by our idea to investigate new compounds that have advantages vis-à-vis initial products. Nevertheless, search for a more potent antibacterial alternative is still a challenge.
Thiazole derivatives as potential drugs were taken into account at the beginning of the 20th century, and nowadays, this interest renewed again (12) . The structure of rhodanine (2-thioxo-4-thiazolidinone) is convenient due to chemical properties: into different positions of thiazolidine cycle by introduction of various substituents, it is possible to get chemical compounds having different biological activity (13, 14) .
Nitrofurans possess a range of positive proper-ties: they enhance phagocytosis and bacteria rarely develop resistance to these compounds, which is related to various and different mechanisms of action (15) . Irrespective of all the facts mentioned above, nitrofurans are used less frequently in clinical practice because of their relatively high toxicity and a large number of side effects (16) . By incorporating pharmacologically active nitrofuran and naphthylamine pharmacophores in one molecule, we expected both to preserve the advantages of antimicrobial preparations and to diminish their disadvantages. The aim of this study was to evaluate the impact of pharmacophores having naphthylamine and nitro groups on the antimicrobial (antibacterial and antifungal) activity of thiazolidinone derivatives. Therefore, it is a therapeutic interest to develop and obtain compounds containing three or more pharmacophores in one molecule.
Materials and Methods
New naphthylamine derivatives (2a-c) were synthesized at the Department of Drug Chemistry, Lithuanian University of Health Sciences (former Kaunas University of Medicine).
Melting points were determined on a Kofl er apparatus with microscope. The IR spectra were recorded in cm -1 for KBr pellets on a SPECORD M80 spectrophotometer.
1 H-NMR spectra were recorded on a Bruker AM 300 spectrometer using DMSOd 6 as a solvent and TMS as the internal reference standard. Chemical shifts are expressed in δ ppm. The purity of compounds was routinely checked by TLC using precoated silica gel plates (Kieselgel 0.25 mm, 60G F254, Merck, Germany). Spots were detected under UV (254 nm). Elemental analysis was performed at the Pharmaceutical Department of Jagiellonian University (Krakow, Poland).
Chemistry
The synthesis of 5-substituted 2-methylmercaptothiazolidin-4-ones (1a-c) is shown in Fig. 1 . The appropriate aldehyde (0.01 mol) was added to solution of 2-methylrhodanine (1.47 g, 0.01 mol) in concentrated acetic acid (10 mL). Ammonium acetate was used as a catalyst. The reaction mixture was stirred for 1 hour at 60°C. After cooling, the solid obtained was fi ltered, washed with acetic acid, then with ether, and dried. The pure product was crystallized from acetic acid.
The A mixture of 4-nitro-1-naphthylamine (2.82 g, 0.015 mol) and solution of appropriate 5-substituted 2-methylmercaptothiazolidin-4-one in acetic acid (0.01 mol) were heated for 2.5 hours at 90°C. Hot suspension was fi ltered, washed with acetic acid, dried, and crystallized from a mixture of 2-butanoldimethylformamide (3:2). All reactions gave a moderate yield.
In Vitro Antimicrobial Activity
Antimicrobial activity of newly synthesized compounds was determined at the Department of Microbiology, the Lithuanian University of Health Sciences (former Kaunas University of Medicine).
Antimicrobial Susceptibility Testing. Antibacterial and antifungal susceptibility was tested in vitro using a serial broth dilution technique (in Mueller-Hinton broth II, BBL, Cockeysville, USA). Antimicrobial activity of new compounds (2a-c) was tested in vitro A standard culture of spore-forming bacteria B. subtilis was cultivated for 7 days on Mueller-Hinton II agar at 35-37°C. After the culture of sporeforming bacteria had grown, it was washed away from the surface of the broth with sterile physiological solution, and the prepared suspension was heated for 30 minutes at 70°C and diluted to the concentration of spores in 1 mL ranging from 10×10 6 to 100×10 6 . Such suspension can be kept for a long time at temperature below 4°C.
The standard fungal cultures -C. albicans, C. glabrata, C. krusei, C. kefyr, C. tropicalis, and C. parapsilosis -were cultivated for 20-24 hours at 30°C on Mueller-Hinton agar (Mueller-Hinton II agar, BBL, Cockeysville, USA). A fungal suspension was prepared from cultivated fungal cultures in physiological solution according to the turbidity standard 0.5 McFarland.
Preparation of Investigative Compounds for Microbiological Analysis. The stock solutions of new compounds (2a-c) (20 000 μg/mL) were prepared in dimethylsulfoxide. Then the dilutions of 0.4, 0.6, 1.25, 2.5, 5, 10, 15.6, 31.25, 62.5, 125, 250, 500, 750, and 1000 μg/mL were done under aseptic conditions by transferring the necessary amount of the analyzed solution using a sterile pipette to other tubes fi lled with 2 mL of Mueller-Hinton broth.
The minimum dilution, i.e., the lowest concentration in μg/mL of the tested and comparison compound that inhibits the growth of bacteria, was determined by the fi rst tube in the series which inhibited visible growth -it was the minimum inhibitory concentration (MIC).
The minimum bactericidal (fungicidal) concentration, defi ned as the minimum concentration of antimicrobial (antifungal) compound that prevents any growth of the tested microorganisms (fungi), was determined by subculturing MIC broth tube without visible growth on Mueller-Hinton agar and incubating for 20-24 hours at temperature of 35-37°C (for bacteria) and at 30°C (for fungi).
Results
All new compounds were successfully synthesized. The structures of new compounds (2a-c) were confi rmed by the elemental analysis and spectral data (IR, NMR). All characteristics of new compounds are shown in Tables 1 and 2 .
For microbiological analysis of synthesized compounds, S. aureus (gram-positive bacterium), E. coli (gram-negative bacillus), B. subtilis (spore-forming bacterium), and K. pneumoniae (capsule-forming bacterium) were chosen considering their different structural characteristics.
As Candida spp. are considered predominant mycotic pathogens (1), the activity of synthesized compounds was investigated against several Candida species: C. albicans, C. glabrata, C. kefyr, C. krusei, C. parapsilosis, and C. tropicalis.
Antifungal and antibacterial activities of new compounds (2a-c) are presented in Table 3 .
Microbiological analysis showed that all new thiazolidinone derivatives with nitronaphthylamine substituent possessed antibacterial and antifungal properties. New compounds 2a-b showed similar antibacterial activity in vitro against S. aureus and B. subtilis as antibiotics aminopenicillins, but they were less active against gram-negative bacteria E. coli (MIC of aminopenicillins is 0.12-8 μg/mL against S. aureus, 1.25-12.5 μg/mL against E. coli, and 0.03-0.25 μg/mL against spore-forming bacterium Bacillus anthracis) (17) .
Discussion
Aldehydes react with 2-methylrhodanine upon heating in acetic acid at 60°C. Boiling makes reactions go faster but yields of products are lower, most likely because 2-methylrhodanine is decomposed. Ammonium acetate was used as a catalyst as higher yields are obtained in this case. The duration of reaction depends on nature of aldehyde. Reactions with nitrofuran derivatives go faster (by forming compounds 1a and 1b); it is enough to heat these compounds with 2-methylrhodanine for 0.5 hour. Reactions with nitrobenzaldehyde go slower (by forming 1c); in this case, the reaction mixture has to be heated for 1 hour. The last-mentioned compound is better soluble in acetic acid compared to compounds having nitrofuran cycle in their structure so reaction mixture of compound 1c is cooled in an ice bath for longer time (for 4 hours). Reaction yields also differ (82%-91%), depending on the nature of aldehyde. Yield of reaction between 3-nitrobenzaldehyde and 2-methylrhodanine is the lowest (82%).
Reactions of intermediate compounds with 4-nitro-1-naphthylamine were carried out in acetic acid. A solvent was chosen according to the solubility of initial compounds 1a-c. Reaction mixture was heated at constant temperature of 90°C because reaction products are decomposed at higher temperature. Reaction process was monitored using a lead acetate indicator. Reaction yields of all newly synthesized compounds were moderate ranging from 53% to 68%. Upon taking double excess of 4-nitro-1-naphthylamine reaction is going faster but separation of reaction product is more complicated.
It is important to note that the activities of newly synthesized compounds were different. The compounds containing a nitrofuryl fragment in their structure (2a-b) were more active against tested bacteria and fungi than that having a nitrobenzyl fragment. The lowest antibacterial activity of all newly synthesized compounds was against capsuleforming bacteria K. pneumoniae and against E. coli (MIC is in range 500-1000 μg/mL). The similar principles of structure-activity relationship were observed in our previous studies (9, 11) . However, the compound 2b having an additional double bond in nitrofuran substituent was similarly active against bacteria as compared with the compound 2a, but it was up to 60 times less active against all fungi except C. kefyr. The compound having a nitrobenzene moiety in its structure (2c) possessed the lowest activity against bacteria and fungi as compared with thiazolidinone derivatives having a nitrofuran fragment (2a-b). Our presumption regarding the introduction of nitrofuran component to achieve higher antimicrobial activity was proved for this time.
However, similar principles could be applied for the estimation of structure-antifungal activity of tested compounds 2a-c. Compound 2a was found to be most active against tested Candida spp. It should be noted that the compound without an additional double bond in nitrofuran component (2a) was more active against C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei, but less active against C. kefyr as compared with the compound containing a nitrofurylallylidene fragment in its structure (2b). It can be presumed that the introduction of these different nitrofuran substituents into the fi fth position of thiazolidinone ring has a different impact on antifungal activity against different fungi. Nevertheless, more detailed experiments should be carried out to confi rm this. Compound 2a possessed similar anticandidal activity as fl uconazole -the most popular antifungal preparation nowadays (18) .
New compounds were found to be bacteriostatic and fungistatic at lower concentrations, but bactericidal and fungicidal at higher concentrations. The fi ndings of this study could further help to develop more active antimicrobial compounds having a thiazolidinone ring in their structure.
Conclusions
Newly synthesized compounds 2a-c having a 4-nitro-1-napthylamine substituent in their structure showed antifungal and antibacterial activities. Naphthylamine derivatives with nitrofuryl and nitrofurylallylidene moieties in the fi fth position of a thiazolidinone ring had similar antibacterial activity in vitro against S. aureus and B. subtilis as aminopenicillins. The compound with a nitrofuryl fragment in the fi fth position of a thiazolidinone ring possessed higher activity against some Candida spp. than fl uconazole. The results indicate that naphthylamine derivatives having a thiazolidinone and especially nitrofuryl fragment in one molecule could be potential antimicrobial compounds.
Statement of Conflict of Interest
The authors state no confl ict of interest. 
Lietuvos sveikatos mokslų universiteto Medicinos akademijos Vaistų chemijos katedra, 2 Vilniaus universiteto Biotechnologijos instituto Biotermodinamikos ir vaistų tyrimo skyrius, 3 Lietuvos sveikatos mokslų universiteto Medicinos akademijos Mikrobiologijos laboratorija, Lietuva
Raktažodžiai: priešgrybelinis aktyvumas, antimikrobinis aktyvumas, naftilaminas, nitrofuranai, tazolidinonas, naujų vaistų sintezė.
